Development of oral lesions in human immunodeficiency virus-infected transfusion recipients and hemophiliacs

American Journal of Epidemiology

Volumn 145, Issue 2, 1997, Pages 164-174

  Hilton, Joan F ^a   Donegan, Elizabeth ^a   Katz, Mitchell H ^b   Canchola, Alison J ^c   Fusaro, Robert E ^d   Greenspan, Deborah ^c   Greenspan, John S ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AIDS Office San Francisco   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

blood transfusion; candidiasis, oral; hemophilia; HIV seroprevalence; leukoplakia, oral; longitudinal studies; oral manifestations; risk factors

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CANDIDIASIS; CHILD; DISEASE TRANSMISSION; FEMALE; HEMOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; LEUKOPLAKIA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEROPREVALENCE; STATISTICAL MODEL; THRUSH;

EID: 0031022604     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009087     Document Type: Article

References (35)

1. Phelan JA, Saltzman BR, Friedland GH, et al. Oral findings in patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol 1987;64:50-6.
2. Melnick SL, Engel D, Truelove E, et al. Oral mucosal lesions: association with the presence of antibodies to the human immunodeficiency virus. Oral Surg Oral Med Oral Pathol 1989;68:37-43.
3. Feigal DW, Katz MH, Greenspan D, et al. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 1991;5: 519-25.
4. Lifson AR, Hilton JF, Westenhouse JL, et al. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS 1994;8:73-9.
5. Lee CA, Phillips AN, Elford J, et al. Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment. BMJ 1991;303:1093-6.
6. Royce RA, Luckmann RS, Fusaro RE, et al. The natural history of HIV-1 infection: staging classifications of disease. AIDS 1991;5:355-64,
7. Katz MH, Greenspan D, Westenhouse J, et al. Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis. AIDS 1992;6:95-100.
8. Saah AJ, Munoz A, Kuo V, et al. Predictors of the risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the Multicenter AIDS Cohort Study. Am J Epidemiol 1992;135:1147-55.
9. Selwyn PA, Alcabes P, Hartel D, et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992; 327:1697-703.
10. Eyster ME, Rabkin CS, Hilgartner MW, et al. Human immunodeficiency virus-related conditions in children and adults with hemophilia: rates, relationship to CD4 counts, and predictive value. Blood 1993;81:828-34.
11. Lin RY, Goodhart P. The role of oral candidiasis in survival and hospitalization patterns: analysis of an inner city hospital human immunodeficiency virus/acquired immune deficiency syndrome registry. Am J Med Sci 1993;305:345-53.
12. Rabeneck L, Crane MM, Risser JM, Lacke CE, Wray NP. A simple clinical staging system that predicts progression to AIDS using CD4 count, oral thrush, and night sweats. J Gen Intern Med 1993;8:5-9.
13. Centers for Disease Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1992;41(RR-4):1-11.
14. Fan-Havard P, Capano D, Smith SM, et al. Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother 1991;35:2302-5.
15. Katz MH, Greenspan D, Heinic GS, et al. Resolution of hairy leukoplakia: an observational trial of zidovudine versus no treatment. (Letter). J Infect Dis 1991;164:1240-1.
16. Fletcher MA, Azen SP, Adelsberg B, et al. Immunophenotyping in a multicenter study: the Transfusion Safety Study experience. Clin Immunol Immunopathol 1989;52:38-47.
17. Lang DJ, Kovacs AA, Zaia JA, et al. Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group. J Acquir Immune Defic Syndr 1989;2:540-9.
18. Busch MP, Taylor PE, Lenes BA, et al. Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group. N Engl J Med 1990;323:1308-12.
19. Donegan E, Stuart M, Niland JC, et al. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med 1990;113: 733-9.
20. Fletcher MA, Mosley JW, Hassett J, et al. Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study Group. Blood 1992; 80:831-40.
21. Donegan E, Lee H, Operskalski EA, et al. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Transfusion 1994;34:478-83.
22. Operskalski EA, Stram DO, Lee H, et al. Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. Transfusion Safety Study Group. J Infect Dis 1995;172:648-55.
23. Wong W-Y, Powars DR, Operskalski EA, et al. Blood transfusions and immunophenotypic alterations of lymphocyte subsets in sickle cell anemia. The Transfusion Safety Study Group. Blood 1995;85:2091-7.
24. Busch MP, Young MJ, Samson SM, et al. Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. The Transfusion Safety Study Group. Transfusion 1991; 31:4-11.
25. Petersen LR, Satten GA, Dodd R, et al. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group. Transfusion 1994;34:283-9.
26. Greenspan JS, Barr CE, Scuibba JJ, et al. Oral manifestations of HIV infection: definitions, diagnostic criteria, and principles of therapy. The U.S.A. Oral AIDS Collaborative Group. Oral Surg Oral Med Oral Pathol 1992;73:142-4.
27. Greenspan D, Greenspan JS, Conant M, et al. Oral "hairy" leucoplakia in male homosexuals: evidence of association with both papillomavirus and a herpes-group virus. Lancet 1984;2:831-4.
28. Diggle PJ, Liang K-Y, Zeger SL. Analysis of longitudinal data. New York, NY: Oxford University Press, Inc, 1994.
29. Goedert JJ, Kessler CM, Aledort LM, et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989;321:1141-8.
30. Kroner BL, Rosenberg PS, Aledort LM, et al. HIV-1 infection incidence among persons with hemophilia in the United States and western Europe, 1978-1990. Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr 1994;7:279-86.
31. Pregibon D. Logistic regression diagnostics. Ann Stat 1981; 9:705-24.
32. SAS Institute, Inc. SAS statistical software, version 6.10 for Microsoft Windows. Cary, NC: SAS Institute, Inc, 1994.
33. Shiboski CH, Hilton JF, Neuhaus JM, et al. HIV-related oral manifestations and gender: a longitudinal analysis. Arch Intern Med 1996;156:2249-54.
34. Shiboski CH, Hilton JF, Greenspan D, et al. HIV-related oral manifestations in two cohorts of women in San Francisco. J Acquir Immune Defic Syndr 1994;7:964-71.
35. Lamster IB, Begg MD, Mitchell-Lewis D, et al. Oral manifestations of HIV infection in homosexual men and intravenous drug users: study design and relationship of epidemiologic, clinical, and immunologic parameters to oral lesions. Oral Surg Oral Med Oral Pathol 1994;78:163-74.